Found 7 matching trials
Extended-release Guanfacine Hydrochloride in Children/Adolescents With Attention-deficit/Hyperactivity
PHASE3A study to evaluate the long term maintenance of efficacy of using Guanfaci...
Location
Maastricht University Medical Centre
Safety and Efficacy of SPD503 in Treating ADHD in Children and Adolescents Aged 6-17
PHASE3The purpose of this study is to determine the efficacy of SPD503 compared t...
Location
Multiple Locations
SPD503 (Guanfacine Hydrochloride) in ADHD Plus Oppositional Symptoms
PHASE3To assess efficacy and safety of SPD503(guanfacine hydrochloride) in subjec...
Location
HOPE Research Institute
A Study of TAK-503 in Children and Teenagers With Attention Deficit Hyperactivity Disorder (ADHD)
PHASE4The main aim of this study is learn more about long-term TAK-503 treatment ...
Location
Harmonex Neuroscience Research
A Drug Interaction Study of SPD503 and Concerta Administered Alone and In Combination in Normal Healthy Volunteers
PHASE1This is a drug-drug interaction study; the purpose of this study is to exam...
Location
Advanced Biomedical Research, Inc.
Access to Extended Release Guanfacine HCl for Subjects Who Participated in Studies SPD503-315 or SPD503-316 in Europe
PHASE3For subjects in Europe that have already participated in either Study SPD50...
Location
Medizinische Universitat Graz Univ fur Kinder
SPD503 in Subjects Aged 6-17 Years With Generalized Anxiety Disorder (GAD), Separation Anxiety Disorder (SAD), or Social Phobia (SoP)
PHASE2This study will evaluate the safety and tolerability of SPD503 in subjects ...
Location
Birmingham Research Group, Inc